Vision insurance; reimbursements; Medicare or Medicaid; non-Medicare reimbursements; charges; services; ophthalmic materials; nonaffiliated labs or frame vendors; effective date.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 5 Compare versions History 5 Sponsors

Feb 11, 2026 · House

Policy recommendation to the Commerce and Economic Development Oversight committee; Do Pass, amended by committee substitute Insurance

Feb 3, 2026 · House

Referred to Insurance

Feb 3, 2026 · House

Second Reading referred to Commerce and Economic Development Oversight

Feb 2, 2026 · House

First Reading

Feb 2, 2026 · House

Authored by Representative Worthen

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Reported from Committee — base rate 14%, measured from OK's completed sessions
Momentum -2 42/100 from the pace of recorded action
Time since last action -22 243 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.